✦ LIBER ✦
PO10-TU-28 MEASURE: a multicentre, single-arm, observational, 96-week, phase IV study to evaluate treatment adherence when using RebiSmart™ for self-injection of Rebif® in multi-dose cartridges in subjects with relapsing multiple sclerosis
✍ Scribed by V. Devonshire; A. Feinstein; P. Moriarty
- Book ID
- 119468126
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 46 KB
- Volume
- 285
- Category
- Article
- ISSN
- 0022-510X
No coin nor oath required. For personal study only.